Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Br J Cancer ; 103(11): 1755-9, 2010 Nov 23.
Article in English | MEDLINE | ID: mdl-21045829

ABSTRACT

BACKGROUND: Oral contraceptive use and reproductive factors may initiate long-term changes to the hormonal milieu and thereby, possibly influence colorectal cancer risk. METHODS: We examined the association of hormonal and reproductive factors with risk of colorectal cancer among 337,802 women in the European Prospective Investigation into Cancer and Nutrition, of whom 1878 developed colorectal cancer. RESULTS: After stratification for center and age, and adjustment for body mass index, smoking, diabetes mellitus, physical activity and alcohol consumption, ever use of oral contraceptives was marginally inversely associated with colorectal cancer risk (hazard ratio (HR), 0.92; 95% confidence interval (CI), 0.83-1.02), although this association was stronger among post-menopausal women (HR, 0.84; 95% CI: 0.74-0.95). Duration of oral contraceptive use and reproductive factors, including age at menarche, age at menopause, type of menopause, ever having an abortion, parity, age at first full-term pregnancy and breastfeeding, were not associated with colorectal cancer risk. CONCLUSION: Our findings provide limited support for a potential inverse association between oral contraceptives and colorectal cancer risk.


Subject(s)
Colorectal Neoplasms/etiology , Contraceptives, Oral/adverse effects , Reproduction , Adult , Aged , Female , Humans , Middle Aged , Prospective Studies , Risk
2.
J Clin Oncol ; 17(10): 3291-8, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10506632

ABSTRACT

PURPOSE: To evaluate and quantify the association between consumption of specific food groups/macronutrients and concentrations of serum insulin-like growth factor 1 (IGF-1) and insulin-like growth factor-binding protein 3 (IGFBP-3). SUBJECTS AND METHODS: Data from a comprehensive food-frequency questionnaire administered to 115 healthy subjects were used to study cross-sectionally the relationship between nutritional factors and circulating IGF-1 and IGFBP-3 concentrations. Adjustment for the effect of total energy intake and a series of epidemiologic parameters (age, sex, height, body mass index, smoking, alcohol consumption, and coffee drinking) was implemented through multivariate linear regression. RESULTS: We observed that serum levels of IGF-1 are positively associated with consumption of red meats, fats, and oils. In addition, serum levels of IGF-1 are independently and positively associated with energy intake from lipids and negatively associated with energy intake from carbohydrates. Finally, serum levels of IGFBP-3 are independently and negatively associated with energy intake from saturated fat. CONCLUSION: Serum IGF-1 and/or IGFBP-3 concentrations are associated with red meat, carbohydrate intake, and fat intake and, thus, may mediate the effect of these dietary factors on the pathogenesis of several disease states. Additional studies are needed to further quantify these associations and elucidate the underlying mechanisms.


Subject(s)
Dietary Carbohydrates/administration & dosage , Dietary Fats/administration & dosage , Insulin-Like Growth Factor Binding Protein 3/blood , Insulin-Like Growth Factor I/metabolism , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Insulin-Like Growth Factor Binding Protein 3/pharmacokinetics , Male , Middle Aged
3.
Am J Clin Nutr ; 70(6): 1077-82, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10584053

ABSTRACT

BACKGROUND: Although several studies showed that risk of rheumatoid arthritis (RA) is inversely associated with consumption of n-3 fatty acids, the one study showing that olive oil may have a protective role has not yet been confirmed. OBJECTIVE: We examined the relation between dietary factors and risk of RA in persons from southern Greece. DESIGN: We studied 145 RA patients and 188 control subjects who provided information on demographic and socioeconomic variables, prior medical and family history, and present disease status. Subjects responded to an interviewer-administered, validated, food-frequency questionnaire that assessed the consumption of >100 food items. We calculated chi-square statistics for linear trend and odds ratios (ORs) for the development of RA in relation to the consumption of olive oil, fish, vegetables, and a series of food groups classified in quartiles. RESULTS: Risk of developing RA was inversely and significantly associated only with cooked vegetables (OR: 0.39) and olive oil (OR: 0.39) by univariate analysis. A significant trend was observed with increasing olive oil (chi-square: 4.28; P = 0.03) and cooked vegetable (chi-square: 10. 48; P = 0.001) consumption. Multiple logistic regression analysis models confirmed the independent and inverse association between olive oil or cooked vegetable consumption and risk of RA (OR: 0.38 and 0.24, respectively). CONCLUSIONS: Consumption of both cooked vegetables and olive oil was inversely and independently associated with risk of RA in this population. Further research is needed to elucidate the underlying mechanisms of this finding, which may include the antioxidant properties or the high n-9 fatty acid content of the olive oil.


Subject(s)
Arthritis, Rheumatoid/prevention & control , Cooking , Diet , Dietary Fats, Unsaturated/administration & dosage , Plant Oils/administration & dosage , Vegetables , Adolescent , Adult , Aged , Aged, 80 and over , Case-Control Studies , Female , Greece , Humans , Male , Middle Aged , Multivariate Analysis , Olive Oil , Surveys and Questionnaires
4.
Invest Ophthalmol Vis Sci ; 40(9): 1921-6, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10440244

ABSTRACT

PURPOSE: Behçet's disease (BD) is known to be associated with HLA-B51 in many different ethnic groups. Recently MICA, a member of a novel family of the human major histocompatibility complex (MHC) class I genes termed MIC (MHC class I chain-related genes), was identified near the HLA-B gene, and a triplet repeat microsatellite polymorphism was found in the transmembrane (TM) region. Because a strong association with BD of one particular MICA-TM allele, A6, was shown in a Japanese population, the present study was conducted to investigate microsatellite polymorphism in Greek patients with BD to know whether this association is generally observed in BD occurring in other populations. METHODS: Thirty-eight Greek patients with BD and 40 ethnically matched control subjects were examined for MICA microsatellite polymorphism using polymerase chain reaction (PCR) and subsequent automated fragment detection by fluorescent-based technology. RESULTS: Similar to the Japanese patients with BD, the phenotype frequency of the MICA-TM A6 allele was significantly increased in the Greek patients with BD (50.0% in control subjects versus 86.8% in BD cases), with an odds ratio (OR) of 6.60 (P = 0.0012). The MICA-A6 allele was found in a high frequency both in males and females (weighted OR = 6.68; P = 0.0017). No association was found between the A6 allele and several disease features. A strong association exists between the MICA-TM A6 allele and the B*5101 allele in both the control subjects and patients with BD (weighted OR = 44.39; P = 0.0000023). CONCLUSIONS: This study revealed in Greek patients a strong association of BD with a particular MICA-TM allele, MICA-A6, providing insight into the molecular mechanism underlying the development of BD.


Subject(s)
Behcet Syndrome/genetics , Eye Proteins/genetics , HLA-B Antigens/genetics , Histocompatibility Antigens Class I/genetics , Membrane Proteins/genetics , Adult , Aged , Alleles , Behcet Syndrome/ethnology , Female , Greece/ethnology , HLA-B51 Antigen , Humans , Male , Middle Aged , Polymerase Chain Reaction , Polymorphism, Genetic , Trinucleotide Repeats/genetics
5.
Hum Immunol ; 59(4): 250-5, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9568801

ABSTRACT

Behçet's disease (BD) is a recurrent systemic vasculitis of unknown etiology. Genetic factors and infectious agents seem to be related to the etiology and pathogenesis of the disease. BD is strongly associated with HLA-B51 antigen in many ethnic groups. As there are differences in HLA profile in different ethnic groups, we designed this case-control study to examine the association of HLA-B51 alleles and BD as well as to investigate the influence of sex, age at development of the International Study Group (ISG) for Behçet's Disease criteria and certain features of disease severity on the strength of this association. The study includes 62 Greek BD patients who fulfill the ISG criteria for Behçet's disease and 87 controls. Serological HLA Class-I typing was performed by standard microlymphocytotoxicity technique. HLA-DNA typing for the B5 group was performed in all B51 subjects and controls by PCR-SSO. Allele B*5101 was found in 80% of BD patients and in 26% of controls (odds ratio (OR) 10.48, p < 10[-6]). Males who carry this allele have a higher risk than females for BD (OR 16.97 and 5.74 respectively). B*5101 predisposes to BD at a younger age in both sexes and to the development of erythema nodosum (OR = 11, p = 0.004). This was confirmed by multiple logistic regression analysis. A weak but not significant association was found between B*5101 and uveitis (OR = 2). No association was found between B*5101 and vasculitis or skin lesions in either sex. It was concluded that in the Greek population allele B*5101 is a predisposing marker for BD, as in most ethnic groups, and that this allele predisposes to the development of the disease at a younger age in both sexes and to the development of erythema nodosum.


Subject(s)
Behcet Syndrome/genetics , Behcet Syndrome/immunology , HLA-B Antigens/genetics , Adolescent , Adult , Case-Control Studies , Child , Female , Greece , HLA-B51 Antigen , Humans , Male
6.
Obstet Gynecol ; 95(6 Pt 1): 810-3, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10831972

ABSTRACT

OBJECTIVE: To determine the effects of treatment with danazol and leuprolide acetate depot on serum-soluble CD23 concentrations in women with endometriosis. METHODS: This randomized trial involved 20 women 18-42 years old with regular menses and known pelvic endometriosis who were recruited from a university hospital between 1993 and 1998. Ten women took 200 mg of danazol three times daily for 6 months, and the remaining ten were given 3.75 mg of leuprolide acetate depot every 28 days for 6 months. Blood-soluble CD23 levels were measured before treatment, during the last 15 days of the 6-month treatment course, and 3 months after treatment. Only one blood sample was taken from ten women without endometriosis, between the 5th and 7th days of their menstrual cycles. For statistical analysis, we used independent and paired t tests with the Pearson correlation coefficient. RESULTS: Soluble CD23 levels were significantly higher in women with endometriosis before treatment than in ten normal controls. Levels decreased significantly during treatment with either danazol or leuprolide acetate. Three months after treatment, soluble CD23 values remained lower than before treatment. There was no correlation between soluble CD23 concentrations and severity of endometriosis. CONCLUSION: Our findings suggest that endometriosis increases soluble CD23 levels, which can be suppressed with either danazol or leuprolide acetate injection.


Subject(s)
Danazol/pharmacology , Endometriosis/blood , Estrogen Antagonists/pharmacology , Fertility Agents, Female/pharmacology , Leuprolide/pharmacology , Receptors, IgE/blood , Adolescent , Adult , Double-Blind Method , Female , Humans
7.
Eur J Obstet Gynecol Reprod Biol ; 98(1): 66-71, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11516802

ABSTRACT

OBJECTIVE: To investigate the role of IL-6, IL-8, and IL-11 in the immune-regulatory mechanisms involved in the spontaneous abortion of the first trimester of pregnancy. STUDY DESIGN: Plasma levels of IL-6, IL-8, and IL-11 were determined in 68 women who had a spontaneous abortion of unknown aetiology during the first trimester of pregnancy. They were compared with the corresponding levels of 73 age-matched pregnant women who had an uneventful pregnancy, and 52 age-matched non-pregnant women. All enrolled women presented without any severe disease, syndrome or recent infection. Cytokine levels were measured by a sensitive sandwich enzyme-linked immunoassay. RESULTS: The women with spontaneous abortion had significantly decreased plasma levels of IL-6, IL-8 and IL-11 compared to those with normal pregnancies (P<0.05). The non-pregnant women had no detectable cytokine levels. CONCLUSIONS: The reduced plasma levels of IL-6, IL-8 and IL-11 in women with spontaneous abortion may be related to the underlying aetiopathogenetic mechanisms, however, there is no sufficient evidence for their use as predictive markers of pregnancy outcome.


Subject(s)
Abortion, Spontaneous/blood , Interleukin-11/blood , Interleukin-6/blood , Interleukin-8/blood , Adolescent , Adult , Birth Weight , Enzyme-Linked Immunosorbent Assay , Female , Gestational Age , Humans , Infant, Newborn , Pregnancy
8.
J Pediatr Adolesc Gynecol ; 14(2): 65-9, 2001 May.
Article in English | MEDLINE | ID: mdl-11479102

ABSTRACT

STUDY OBJECTIVE: To determine the concentration of plasma carnitine (total, free, and acylcarnitine) during the delivery of uncomplicated pregnancies of adolescent women. To investigate the relationship between maternal and neonatal levels of carnitine and to compare these carnitine levels between pregnant and nonpregnant adolescents. DESIGN: Samples of maternal and umbilical blood were taken at the time of delivery and examined for the determination of the carnitine-total, free, and acylcarnitine-concentration by the use of an enzymatic-radioisotope method. Twenty-two cases of uncomplicated adolescent pregnancies with a normal labor and without perinatal complications were examined. The plasma level of carnitine was also examined in 17 healthy nonpregnant adolescent women, which constituted the control group. RESULTS: The concentrations of plasma carnitine in adolescent pregnancies at the time of delivery were calculated at 19.6 +/- 2.15 microMol/L (total), 12.62 +/- 1.31 microMol/L (free), and 6.98 +/- 1.55 microMol/L (acylcarnitine). The corresponding mean values in umbilical plasma were 30.31 +/- 2.06 microMol/L, 22.39 +/- 1.64 microMol/L, and 7.92 +/-.96 mucroMol/L. There is a statistically significant difference between the mean values in maternal and umbilical plasma (P <.0001 for total and free carnitine and P <.012 for acylcarnitine). The correlations between adolescent pregnant women and their infants as regards total, free, and acylcarnitine were 0.137, 0.018, and 0.33, respectively. Neither of these parameters was statistically significant. The corresponding mean values of carnitine in nonpregnant adolescent women were statistically significantly higher than in adolescent pregnant women (total carnitine: 41.61 +/- 3.09 microMol/L, free: 31.39 +/- 2.81 microMol/L, acylcarnitine: 10.22 +/- 1.88 microMol/L, P <.0001). CONCLUSIONS: The concentration of plasma carnitine at the end of adolescent pregnancy is low compared to the levels of umbilical carnitine at birth and that found in nonpregnant adolescent women. It may not have an obvious impact on the utilization of fatty acids in an uncomplicated full-term pregnancy; however, it suggests the potential risk for neonatal fatty-acid oxidation in a preterm or complicated pregnancy.


Subject(s)
Carnitine/blood , Labor, Obstetric/blood , Pregnancy in Adolescence/blood , Adolescent , Case-Control Studies , Female , Fetal Blood/metabolism , Humans , Infant, Newborn , Pregnancy
9.
Int J Fertil Womens Med ; 45(3): 236-40, 2000.
Article in English | MEDLINE | ID: mdl-10929687

ABSTRACT

OBJECTIVE: To confirm the presence of L-carnitine in human seminal plasma, to show differences between L-carnitine concentrations in fertile and infertile subjects, and to show potential relationships between L-carnitine and semen quality. STUDY DESIGN: Seminal plasma from 101 men obtained by masturbation was examined for the presence of L-carnitine. Semen samples were divided as follows: (a) in eight groups according to the etiology of fertility, (b) in two groups on the basis of normal or abnormal spermiogram, (c) correlation of the amount of L-carnitine in seminal plasma with values of the spermiogram. RESULTS: We found the following: (1) L-carnitine levels differ significantly between controls and the patient groups (P < .0001) (2) The group with normal spermiogram has a mean value for L-carnitine of 478.4 while the abnormal one comes to 100.58. This difference is statistically significant (P < .0001). (3) There is a statistically significant, positive correlation between L-carnitine and the number of spermatozoa, the percentage of motile spermatozoa, and the percentage of normal forms (P < .0001). CONCLUSION: These findings suggest that determination of seminal carnitine values might provide the physician with an additional means of evaluating the infertile male.


Subject(s)
Carnitine/analysis , Infertility, Male/diagnosis , Semen/chemistry , Spermatozoa/physiology , Adult , Humans , Male , Middle Aged , Predictive Value of Tests , Semen/cytology , Sperm Motility , Spermatozoa/cytology
10.
Eur J Gynaecol Oncol ; 19(2): 170-2, 1998.
Article in English | MEDLINE | ID: mdl-9611060

ABSTRACT

Low-malignant potential (LMP) epithelial tumors of the ovary are a group which occupy an intermediate position between the benign and those of the frankly malignant ovarian neoplasms. The actual incidence, present age and treatment are still being discussed. During the period 1991-1996, from the 650 ovarian tumors which were diagnosed and treated in our institution, 401 were epithelial tumors. The LMP serous epithelial tumors consisted of 4.36% of all serous tumors while LMP mucinous tumors were 9.70% of all mucinous tumors. The LMP serous tumors had an 8 cm diameter on average, 83% were unilocular and 76.5% unilateral. The LMP mucinous tumors had a 17 cm diameter on average, 95% were multilocular and 95% unilateral. The mean age at diagnosis was 39 years for LMP serous tumors and 48 years for LMP mucinous tumors.


PIP: The incidence and clinical features of low-malignant potential (LMP) epithelial tumors of the ovary were investigated in a review of the 650 ovarian tumor cases diagnosed and treated at the University of Crete (Greece) Department of Obstetrics and Gynecology in 1991-96. 401 of these cases were epithelial tumors. Of these, 282 (70.32%) were benign, 96 (23.94%) were malignant, and 23 (5.74%) were LMP. LMP serous epithelial tumors accounted for 4.36% of all serous tumors while LMP mucinous tumors contributed 9.70% of the mucinous tumors. LMP serous tumors averaged 8 cm in diameter; 83% were unilocular and 76.5% were unilateral. LMP mucinous tumors averaged 17 cm in diameter; 95% were multilocular and 95% were unilateral. The primary presenting symptoms were pelvic pain (35%), palpable mass (30%), and menstrual aberrations (15%). Only 1 case of extra-ovarian metastasis was reported. The mean age at diagnosis was 39 years for LMP serous tumors and 48 years for LMP mucinous tumors. Prognosis for women with stage I ovarian tumors of LMP is excellent, with a 99% survival rate.


Subject(s)
Adenocarcinoma, Mucinous/epidemiology , Adenocarcinoma, Mucinous/pathology , Cystadenocarcinoma, Serous/epidemiology , Cystadenocarcinoma, Serous/pathology , Ovarian Neoplasms/epidemiology , Ovarian Neoplasms/pathology , Adenocarcinoma, Mucinous/surgery , Adolescent , Adult , Age Distribution , Aged , Cystadenocarcinoma, Serous/surgery , Disease-Free Survival , Female , Follow-Up Studies , Greece/epidemiology , Humans , Incidence , Middle Aged , Ovarian Neoplasms/surgery , Risk Factors , Survival Rate
11.
Clin Exp Obstet Gynecol ; 26(2): 118-9, 1999.
Article in English | MEDLINE | ID: mdl-10459456

ABSTRACT

The present study was designed to investigate the participation of sCD23 and TNF-alpha in pregnant women in the first trimester. One hundred and forty-one patients were enrolled in the study. Women were classified into two groups. Serum sCD23 and TNF-alpha were measured in 73 normal pregnant women in the first trimester (Group I) and in 68 women with spontaneous abortion (Group II). We found that the mean values of TNF-alpha levels were higher in women with normal pregnancy than in women with spontaneous abortion (p < 0.05), whereas sCD23 levels of women in group II did not differ statistically from the controls. These results sustain the opinion that women with spontaneous abortion seem to have reduced TNF-alpha levels. However, determination of these immunological parameters provides no useful clinical information about disease activity and management.


Subject(s)
Abortion, Spontaneous/blood , Pregnancy Trimester, First/blood , Receptors, IgE/blood , Tumor Necrosis Factor-alpha/metabolism , Abortion, Induced , Adolescent , Adult , Female , Gestational Age , Gravidity , Humans , Immunoenzyme Techniques , Pregnancy
12.
Prenat Diagn ; 21(7): 566-70, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11494293

ABSTRACT

Fetal trophoblasts can be found in maternal circulation from an early stage of pregnancy and thus provide a potential source of DNA for non-invasive prenatal diagnosis. We have developed a two-step method for trophoblast isolation between the 8th and 12th week of pregnancy. Blood was sampled from 14 women undergoing termination of pregnancy or spontaneous abortion. Immunomagnetic beads precoated with HLA class I and II, and with anti-cytokeratin-18 monoclonal antibodies, were used to remove CD8+ and other maternal cells, and to select for fetal trophoblasts, respectively. Microsatellite analysis was performed on DNA extracted from the isolated, maternal, paternal and placental cells after PCR amplification. Recovery of the trophoblasts was confirmed in 13/14 cases (93%) by the identification of an identical microsatellite pattern for fetal and placental cells. Further evidence was the presence of heterozygous alleles of both maternal and paternal origin. The correct prediction of gender in all five male fetuses was an additional confirmation of trophoblast recovery. We conclude that trophoblasts can be effectively isolated from maternal blood in the first trimester, and by using polymorphic microsatellite markers to confirm sample purity, this method has potential future application in prenatal diagnosis.


Subject(s)
Chromosome Aberrations/diagnosis , Fetal Diseases/diagnosis , Microsatellite Repeats , Prenatal Diagnosis/standards , Trophoblasts/cytology , Adolescent , Adult , Antibodies, Monoclonal , Chromosome Aberrations/blood , Chromosome Disorders , DNA/isolation & purification , Female , Fetal Diseases/blood , Humans , Male , Polymerase Chain Reaction , Predictive Value of Tests , Pregnancy , Pregnancy Trimester, First , Prenatal Diagnosis/methods
13.
Gynecol Obstet Invest ; 51(3): 150-6, 2001.
Article in English | MEDLINE | ID: mdl-11306899

ABSTRACT

The aim of this study was to investigate the efficacy of recombinant human erythropoietin (rHuEPO) combined with parenteral iron, in the treatment of moderate and severe iron deficiency anemia during pregnancy. Twenty-six pregnant women, who had been ineffectively treated with iron supplementation alone for at least 8 weeks, were enrolled. They met the following criteria for inclusion in the study: hemoglobin (Hb) concentration <8.5 g/dl, evidence of iron deficiency anemia, and absence of other pregnancy complications, or severe systemic diseases. The treatment protocol comprised of a combination therapy with 150 IU/kg rHuEPO subcutaneously three times per week and 100 mg parenteral iron daily, for a total period of 4 weeks. Nineteen out of 26 women (73%) showed a quick response, with Hb reaching normal levels within the first 2 weeks of treatment. They displayed an average of 3.17 g/dl increase in Hb concentration during the total period of therapy, with 3.0 g/dl increase within the first 2 weeks. In 5 women (19.2%) there was no significant increase in Hb levels, while in 2 women (7.6%) a further decline in Hb concentration was observed, that necessitated a blood transfusion. In conclusion, rHuEPO combined with parenteral iron is an effective treatment for moderate and severe iron deficiency anemia during pregnancy, with minimal adverse or side effects. It may serve as an alternative to blood transfusion, or in cases of resistant anemia that are not effectively treated by iron supplementation alone. However, further studies are needed to investigate the poor response observed in about 25% of treated patients.


Subject(s)
Anemia, Iron-Deficiency/drug therapy , Erythropoietin/therapeutic use , Pregnancy Complications, Hematologic/drug therapy , Adult , Anemia, Iron-Deficiency/blood , Blood Transfusion , Erythrocyte Indices , Erythropoietin/administration & dosage , Female , Gestational Age , Hematocrit , Hemoglobins/analysis , Humans , Iron/administration & dosage , Iron/therapeutic use , Pregnancy , Recombinant Proteins , Reticulocyte Count , Treatment Outcome
14.
Int J Cancer ; 49(3): 377-80, 1991 Sep 30.
Article in English | MEDLINE | ID: mdl-1655659

ABSTRACT

A recently introduced enzyme immunoassay procedure for antibodies against the hepatitis-C virus (HCV) was used to test samples from 185 cases with hepatocellular carcinoma (HCC) and 432 hospital controls. The anti-HCV results were examined in conjunction with previously reported data from this study concerning hepatitis-B virus (HBV) serology, hepatitis-D virus (HDV) antibodies, presence of cirrhosis and tobacco smoking. There was evidence for interaction between HBV and HCV in the causation of HCC: as previously reported, the rate ratio (RR) linking the presence of anti-HCV to HCC among subjects positive for hepatitis-B surface antigen (HBsAg) was substantially higher than the corresponding RR among those negative for this marker; furthermore, among HCC patients positive for HBsAg, a high proportion (33/61) of those who were positive for hepatitis-Be antigen (HBeAg) or its antibody were positive for anti-HCV, whereas among HBsAg-positive controls who were also positive for HBeAg or its antibody, none was positive for anti-HCV (0/18; p less than 10(-4)). The anti-HCV-related RR for HCC was also higher among HCC patients with cirrhosis than among those without evidence of co-existing cirrhosis (RR 11.4 vs. 4.4; p = 0.06). In addition, there was some evidence of interaction between tobacco smoking and HCV in the origin of HCC; after controlling for age, sex and HBsAg status, the RR for subjects positive for anti-HCV was 6.8 among smokers but only 3.2 among non-smokers (p = 0.26). By contrast, there was no suggestion of an interaction between anti-HCV and anti-HDV, in agreement with the presumed minimal role, if any, of HDV in HCC etiology. These results support the notion that HCV is involved in the etiology of HCC by advancing, through a chronic liver disease process, carcinogenesis initiated by other factors.


Subject(s)
Carcinoma, Hepatocellular/etiology , Hepacivirus/immunology , Hepatitis B Surface Antigens/analysis , Liver Neoplasms/etiology , Aged , Carcinoma, Hepatocellular/epidemiology , Case-Control Studies , Female , Greece/epidemiology , Hepatitis B e Antigens/analysis , Humans , Liver Neoplasms/epidemiology , Male , Middle Aged , Smoking/adverse effects
15.
Int J Cancer ; 43(5): 795-9, 1989 May 15.
Article in English | MEDLINE | ID: mdl-2714884

ABSTRACT

Eighty-three women with invasive adenocarcinoma of the endometrium and 164 control women hospitalized for various orthopedic conditions were interviewed regarding demographic, reproductive, socio-economic and biomedical characteristics, including their use of tobacco, drugs and exogenous estrogens. The data were analyzed by modelling rate ratio (r) through multiple logistic regression. The main results were as follows: women with invasive adenocarcinoma of the endometrium had earlier menarche (r = 0.82 for every additional year; one-tailed p approx. 0.04), later menopause (r = 1.50 for a 5-year difference; one-tailed p approx. 0.004), and fewer live-born children (r = 0.86 for every additional child; one-tailed p approx. 0.08); they were also taller (r = 1.33 for a 5-cm difference; one-tailed p approx 0.03), whereas weight, adjusted for height, was not a statistically significant risk indicator (one-tailed p approx. 0.38). Regular use of combination oral contraceptives was associated with a reduced risk of endometrial cancer (r = 0.56), whereas intake of menopausal estrogens for more than 6 months was associated with an increased risk (r = 2.04); however, because of the low frequency of use of exogenous estrogen preparations in Greece, neither of these 2 results was statistically significant. Tobacco smoking was associated with a significantly reduced risk of endometrial cancer; smoking 15-20 cigarettes per day for 20 years was associated with a rate ratio of 0.49 (one-tailed p approx. 0.03). The protective effect of tobacco smoking was evident only among post-menopausal women. These results indicate that the risk profile of endometrial cancer is similar in high-risk and low-risk countries, and underline the importance of unopposed estrogenic stimulation in the pathogenesis of this cancer.


Subject(s)
Uterine Neoplasms/epidemiology , Adult , Age Factors , Aged , Contraceptives, Oral , Demography , Female , Greece , Humans , Menopause , Middle Aged , Pregnancy , Risk Factors , Smoking , Urban Population , Uterine Neoplasms/etiology
16.
JAMA ; 265(15): 1974-6, 1991 Apr 17.
Article in English | MEDLINE | ID: mdl-1848908

ABSTRACT

Serum taken from patients in a case-control study in Athens, Greece, was used to examine the interactive roles of hepatitis B virus (HBV) and hepatitis C virus (HCV) in the origin of hepatocellular carcinoma (HCC). An enzyme immunoassay for anti-HCV was used to test serum taken from 185 cases with HCC, 35 cases with metastatic liver cancer (MLC), and 432 hospital controls. Weakly positive anti-HCV results were more strongly related to MLC than to HCC, implying that these anti-HCV results are false positive. By contrast, strongly positive anti-HCV results were significantly related to HCC (relative risk [RR], 6.3), whereas no significant association was evident for MLC (RR, 0.6). The association of anti-HCV with HCC was substantially higher among subjects whose radioimmunoassay was positive for hepatitis B surface antigen (RR, 20.0) than among those whose radioimmunoassay was negative for this marker (RR, 4.8). These findings indicate that HCV infection has an interactive role in the origin of HCC.


Subject(s)
Carcinoma, Hepatocellular/microbiology , Hepacivirus , Hepatitis B virus , Hepatitis B/microbiology , Hepatitis C/microbiology , Liver Neoplasms/microbiology , Aged , Case-Control Studies , Female , Greece , Hepacivirus/immunology , Hepatitis Antibodies/analysis , Hepatitis B/immunology , Hepatitis B Surface Antigens/analysis , Hepatitis B virus/immunology , Hepatitis C/immunology , Humans , Liver Neoplasms/secondary , Male , Middle Aged , Regression Analysis , Sensitivity and Specificity
17.
FEMS Microbiol Immunol ; 3(4): 205-10, 1991 Aug.
Article in English | MEDLINE | ID: mdl-1931133

ABSTRACT

The effect of a purified glycoprotein extract from Klebsiella pneumoniae with non-specific immunostimulating properties (RU 41740) on the development and course of mycoplasma arthritis was investigated. Male A/J mice aged 2-3 months were given RU-41740 either intraperitoneally (i.p.) or orally prior to injection with Mycoplasma arthritidis. RU-41740 injected i.p. at 0.1 mg kg-1 or given orally at 1 mg kg-1 prior to the infection and subsequently on alternate days enhanced the resistance of mice to mycoplasma arthritis (P less than 0.001). Doses of 1 mg kg-1 i.p. or 10 mg kg-1 orally did not modify the course of the arthritis significantly, probably due to immunosuppressive factors from monocytes. It is suggested that RU-41740 protects the mice by stimulating macrophages. This immunostimulant might prove useful in the treatment of mycoplasma diseases, especially in the immunocompromised host.


Subject(s)
Adjuvants, Immunologic/pharmacology , Arthritis, Infectious/immunology , Bacterial Proteins/pharmacology , Mycoplasma Infections/immunology , Animals , Arthritis, Infectious/pathology , Male , Mice , Mycoplasma/isolation & purification , Mycoplasma Infections/pathology
18.
Scand J Rheumatol ; 20(6): 419-26, 1991.
Article in English | MEDLINE | ID: mdl-1771399

ABSTRACT

In an interview based, case control study of Rheumatoid Arthritis (RA) 168 cases and 137 controls were included. Patients and controls were interviewed with regard to a variety of socioeconomic, medical and dietary factors. During univariate analysis it was found that RA cases consumed significantly less olive oil and fish and adhered more rarely to the dietary restrictions traditional in Orthodox lent than controls. Applying multiple logistic analysis though (by which several variables were controlled for), only the association with olive oil consumption and lent adherence remained significant. More specifically; an increase in olive oil consumption by two times per week, resulted in a Relative Risk (RR) for development of RA of 0.49, whereas adherence to lent during the 27 weeks per year prescribed by the Orthodox Church, resulted in a RR of 0.33. We conclude that olive oil consumption and adherence to Orthodox lent may have a protective effect on the development and/or the severity of RA. This is a hypothesis generated by the present study that needs verification.


Subject(s)
Arthritis, Rheumatoid/epidemiology , Arthritis, Rheumatoid/prevention & control , Diet , Fishes , Plant Oils/pharmacology , Administration, Oral , Adult , Aged , Aged, 80 and over , Animals , Arthritis, Rheumatoid/etiology , Case-Control Studies , Female , Humans , Male , Middle Aged , Olive Oil , Plant Oils/administration & dosage , Risk Factors , Socioeconomic Factors
19.
Int J Cancer ; 39(1): 45-9, 1987 Jan 15.
Article in English | MEDLINE | ID: mdl-3025110

ABSTRACT

Tobacco smoking and alcohol drinking histories were obtained from 194 patients with hepatocellular carcinoma (HCC) and 456 hospital controls, and the results were analysed in conjunction with the results of serological determinations of hepatitis B surface antigen (HBsAg), antibody to HBsAg (anti-HBs) and antibody to hepatitis B core antigen (anti-HBc) in all subjects, as well as the presence or absence of cirrhosis in HCC patients. The relative risk (RR) of HCC (and 95% confidence interval) among HBsAg-positive subjects was 13.7 (8.0-23.5), whereas the excess risk among antibody-positive subjects was small and statistically non-significant. In the presence of cirrhosis the RR for HBsAg-positive subjects was considerably higher (30.7 vs. 7.1 among HBsAg-positive subjects without cirrhosis) indicating that HBV may affect the development of HCC through at least two different and potentially multiplicative mechanisms (DNA integration and liver regeneration). Moderate ethanol consumption does not affect the risk of HCC, but there is a statistically significant and dose-dependent association between tobacco smoking and HBsAg-negative HCC. In most of the developed countries of Europe and North America, where the prevalence of HBsAg carrier state is very low and tobacco smoking very common, more cases of HCC may be due to tobacco smoking than to HBV, even though the RR for HCC is much higher among HBsAg carriers than among tobacco smokers.


Subject(s)
Alcohol Drinking , Carcinoma, Hepatocellular/etiology , Hepatitis B/complications , Liver Neoplasms/etiology , Smoking , Adult , Aged , DNA, Viral/analysis , Female , Hepatitis B virus/genetics , Humans , Liver Cirrhosis/complications , Male , Middle Aged
20.
Eur J Immunogenet ; 24(4): 265-74, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9306095

ABSTRACT

The association of certain HLA-DRB1 alleles in Green rheumatoid arthritis (RA) patients with several features of the disease, the gender of the patient and the age at onset was investigated. This case control study includes 86 Greek RA patients and 130 healthy controls unrelated to the patients. HLA typing was performed by polymerase chain reaction (PCR) and hybridization with sequence-specific oligonucleotide (SSO) probes. HLA-DR4 was significantly increased in RA patients. The alleles *0101, *0401, *0405 and *1001 were associated with a higher risk of RA. The *0408 allele was absent from our patients. Sixty-five per cent of RA patients carried the 'sharp epitope' (SE) compared with 31.5% of controls. The risk for RA in individuals carrying a single allele positive for SE was 2.85 times higher, and for those carrying two alleles positive for SE 8.57 times higher, than in SE-negative individuals. The risk was higher in those carrying the *0401 allele, followed by *0405 and *0101, while the genotype *0401/*0404 was absent. Alleles positive for SE comprise a predisposing factor for RA at an early age, particularly in men, and are associated with positive rheumatoid factor, nodules and erosions.


Subject(s)
Arthritis, Rheumatoid/genetics , Gene Frequency , Genes, MHC Class II/genetics , HLA-DR Antigens/genetics , Adult , Age Factors , Aged , Aged, 80 and over , Arthritis, Rheumatoid/immunology , Case-Control Studies , Epitopes , Female , Greece , HLA-DRB1 Chains , Histocompatibility Testing , Humans , Male , Middle Aged , Polymorphism, Genetic , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL